News-Medical.Net on MSN
Revolutionizing 3D cell culture with simplified digital microfluidic technology
Most cells in the human body exist in complex three-dimensional environments, yet they are still commonly studied on flat plastic dishes. These two-dimensional cultures distort cell behavior, limiting ...
In a recent review article published in the journal Microsystems & Nanoengineering, researchers explored the advancements in microfluidic technologies for monitoring the electromechanical activity of ...
Aircraft wing-shaped structures inside tiny channels produce consistent drug delivery particles at any scale, from small laboratory tests to factory production, while substantially cutting costs.
(Nanowerk News) In a recently published study in Analyst ("From mouth to gut: microfluidic in vitro simulation of human gastro-intestinal digestion and intestinal permeability"), INL researchers ...
Dielectrophoresis (DEP) is an electrokinetic phenomenon that induces the motion of polarisable particles in a non-uniform electric field. This method, utilised within microfluidic devices, has evolved ...
EMERYVILLE, Calif.--(BUSINESS WIRE)--Nutcracker Therapeutics, Inc., a contract, research, development and manufacturing organization (CRDMO) with a next generation RNA precision manufacturing platform ...
Researchers at Koç University have developed an open-access, machine learning–assisted tool that automates microfluidic chip design, lowering the ...
In a recent study published in eBioMedicine, researchers developed the Flexible, Robust, Equipment-free Microfluidic (FREM) platform for malaria screening and Plasmodium species genotyping. Study: A ...
Global Microfluidic Devices Market to Expand at 9.75% CAGR as Demand for Point-of-Care Testing, Personalized Medicine, and High-Throughput Research Accelerates.Austin, Texas, Jan. 23, 2026 (GLOBE ...
The image shows culture, release and transfer of the tumoroids from the ReSCUE platform, as well as the released breast cancer disk-, rod-, and U-shaped tumoroids cultured in EKGel over 0, 7, 14 and ...
Gyros has completed the separate sales of two microfluidic system platforms to AstraZeneca and Cambridge Antibody Technology (CAT). The system sales, which took place in April 2006 prior to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results